Streamlined, cost-effective and value add approach
to de-risking mechanism and drug function
EFFICIENT SCREENING OF IO DRUG CANDIDATES
Our Approach
We aim to bridge the translational gap by incorporating clinical evidence into novel assays and model systems to accelerate IND-enabling studies
Our Mission
“Our mission as a team is to be the leader in developing and providing our partners with translational systems to accelerate immuno-oncology (IO) research. We tailor our model systems to fit the needs of our partners by offering a unique set of cell chains and providing detailed reports with our findings.”
Our Objectives
- Streamline the IND-enabling process by providing the “tool box” of cells, assays, model systems.
- Connect the immunology “dots” in developing a drug profile for our partners.
- Be innovative and cost-effective in our approach to services.
- Think like a biotech
NEWS & EVENTS
Latest news and press releases
Mission Statement
“Our mission as a team is to be the leader in developing and providing our partners with translational systems to accelerate immuno-oncology (IO) research. We tailor our model systems to fit the needs of our partners by offering a unique set of cell chains and providing detailed reports with our findings.”
What is Immuno-Oncology (IO)?
Immuno-oncology is a method of immunotherapy used to target and treat various cancers. This method works in a different way than more traditional ways of fighting cancer, such as chemotherapy or radiation. IO uses the body’s own immune system to fight against cancerous cells.
